Discovery of novel imidazo [1, 2-a] pyrazin-8-amines as Brk/PTK6 inhibitors

…, H Miao, JB Bracken, MA Siddiqui, M Malkowski…

Index: Zeng, Hongbo; Belanger, David B.; Curran, Patrick J.; Shipps Jr., Gerald W.; Miao, Hua; Bracken, Jack B.; Arshad Siddiqui; Malkowski, Michael; Wang, Yan Bioorganic and Medicinal Chemistry Letters, 2011 , vol. 21, # 19 p. 5870 - 5875

Full Text: HTML

Citation Number: 16

Abstract

A series of substituted imidazo [1, 2-a] pyrazin-8-amines were discovered as novel breast tumor kinase (Brk)/protein tyrosine kinase 6 (PTK6) inhibitors. Tool compounds with low- nanomolar Brk inhibition activity, high selectivity towards other kinases and desirable DMPK properties were achieved to enable the exploration of Brk as an oncology target.

Related Articles:

Synthesis and SAR studies of imidazo-[1, 2-a]-pyrazine Aurora kinase inhibitors with improved off-target kinase selectivity

[Voss, Matthew E.; Rainka, Matthew P.; Fleming, Mike; Peterson, Lisa H.; Belanger, David B.; Siddiqui, M. Arshad; Hruza, Alan; Voigt, Johannes; Gray, Kimberly; Basso, Andrea D. Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 10 p. 3544 - 3549]

More Articles...